Date: January 21, 2021 Source 1: Rockefeller University Source 2: www.sciencedaily.com Summary: Study participants continued to improve their antibodies months after initial infection, potentially due to exposure to remnants of the virus hidden in the gut. As the number of people who have fought off SARS-CoV-2 climbs ever higher, a critical question has grown in […]
Date: August 17, 2020 Source 1: Ruhr-University Bochum Source 2: www.sciencedaily.com Summary: Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2. A test helps to adapt therapy following an infection. A research team from the University Hospital at Ruhr-Universität Bochum (RUB) has developed a test that provides information on the
NIAID-sponsored Phase 1 trial tested mRNA vaccine Date: July 14, 2020 Source 1: NIH/National Institute of Allergy and Infectious Diseases Source 2: www.sciencedaily.com Summary: An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to
